Study of Photodynamic Therapy (PDT) in Patients With Central Serous Chorioretinopathy (CSC)

P

Peking University

Status and phase

Completed
Phase 4

Conditions

Central Serous Chorioretinopathy

Treatments

Procedure: PDT

Study type

Interventional

Funder types

Other

Identifiers

NCT01574430
PDTCSC-CHINA

Details and patient eligibility

About

The purpose of this study is to determine the safety and efficacy of PDT at 30% verteporfin dose in the treatment of CSC.

Enrollment

131 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with CSC
  • patients signed the ICF
  • patients with course of CSC less than 6 months
  • patients did not undertake any treatment for CSC

Exclusion criteria

  • patients with porphyria
  • patients allergic to verteporfin
  • pregnant or nursing women
  • poor patients compliance
  • sever liver dysfunction
  • dioptric media opacities which make it difficult to exam fundus

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

131 participants in 2 patient groups

50% dose PDT
Active Comparator group
Description:
patients in this group was given 50% verteporfin dose PDT
Treatment:
Procedure: PDT
30% dose PDT
Experimental group
Description:
patients in this group was given 30% verteporfin dose PDT
Treatment:
Procedure: PDT

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems